[AMRX] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 218.06%
YoY- 109.86%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 659,191 616,981 620,040 599,046 557,540 609,759 545,557 13.43%
PBT -75,522 -83,461 22,957 29,660 -9,426 -7,655 2,180 -
Tax 6,156 9,883 -2,076 -23 668 -1,797 4,570 21.94%
NP -91,643 -98,649 9,682 11,917 -10,094 -5,858 -2,390 1034.58%
Tax Rate - - 9.04% 0.08% - - -209.63% -
Total Cost 750,834 715,630 610,358 587,129 567,634 615,617 547,947 23.34%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -13.90 -15.99 1.56 1.99 -1.81 -0.96 -0.44 897.23%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.30 -0.40 0.06 0.08 -0.07 -0.04 -0.02 507.21%
EPS Diluted -0.30 -0.40 0.06 0.08 -0.07 -0.04 -0.02 507.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.